Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IRMDNASDAQ:RXSTNASDAQ:SIBNNASDAQ:SKIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIRMDIradimed$60.64-0.2%$52.80$41.71▼$63.29$771.04M0.9143,279 shs51,276 shsRXSTRxSight$14.91-2.3%$15.58$12.53▼$60.81$605.82M1.29699,597 shs405,480 shsSIBNSI-BONE$19.05+3.0%$15.90$11.70▼$20.05$811.69M0.82380,941 shs934,292 shsSKINBeauty Health$1.60-4.5%$1.29$0.78▼$2.24$200.96M1.171.03 million shs554,917 shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIRMDIradimed+1.66%+17.65%+16.21%+16.01%+42.14%RXSTRxSight-3.48%-5.22%+4.23%-40.30%-73.24%SIBNSI-BONE-2.17%0.00%+29.75%+13.02%+34.47%SKINBeauty Health+1.21%+1.21%+57.55%+32.54%-20.85%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIRMDIradimed4.787 of 5 stars2.53.02.54.44.03.31.9RXSTRxSight3.0056 of 5 stars4.21.00.00.03.12.50.6SIBNSI-BONE3.9031 of 5 stars2.53.00.03.34.12.50.6SKINBeauty Health0.6383 of 5 stars0.81.00.00.03.43.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIRMDIradimed 3.00Buy$72.0018.73% UpsideRXSTRxSight 2.30Hold$37.90154.23% UpsideSIBNSI-BONE 3.00Buy$22.5018.13% UpsideSKINBeauty Health 1.67Reduce$1.42-11.18% DownsideCurrent Analyst Ratings BreakdownLatest SKIN, SIBN, IRMD, and RXST Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2025RXSTRxSightWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$17.00 ➝ $25.005/6/2025SIBNSI-BONETruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$20.00 ➝ $22.005/6/2025SIBNSI-BONECantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$25.00 ➝ $25.005/6/2025SIBNSI-BONENeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$24.00 ➝ $24.005/5/2025SKINBeauty HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$1.50 ➝ $1.254/15/2025RXSTRxSightPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$18.004/9/2025RXSTRxSightUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$45.00 ➝ $16.004/4/2025RXSTRxSightJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Underweight$40.00 ➝ $17.004/3/2025RXSTRxSightWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$35.00 ➝ $22.004/3/2025RXSTRxSightBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Underperform$36.00 ➝ $22.004/3/2025RXSTRxSightNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$43.00 ➝ $43.00(Data available from 6/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIRMDIradimed$75.15M10.26$1.51 per share40.12$5.66 per share10.71RXSTRxSight$148.31M4.08N/AN/A$4.47 per share3.34SIBNSI-BONE$176.60M4.60N/AN/A$4.18 per share4.56SKINBeauty Health$322.47M0.62N/AN/A$0.48 per share3.32Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIRMDIradimed$19.23M$1.5540.4330.32N/A26.26%24.12%21.20%7/30/2025 (Estimated)RXSTRxSight-$48.61M-$0.67N/AN/AN/A-23.92%-14.00%-12.51%8/4/2025 (Estimated)SIBNSI-BONE-$43.34M-$0.64N/AN/AN/A-23.82%-22.51%-16.53%8/4/2025 (Estimated)SKINBeauty Health-$100.12M-$0.41N/AN/AN/A-8.11%-44.83%-3.54%8/14/2025 (Estimated)Latest SKIN, SIBN, IRMD, and RXST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025SKINBeauty Health-$0.13-$0.08+$0.05-$0.08$63.88 million$69.60 million5/7/2025Q1 2025RXSTRxSight-$0.03-$0.03N/A-$0.20$38.74 million$37.90 million5/5/2025Q1 2025SIBNSI-BONE-$0.24-$0.15+$0.09-$0.15$45.13 million$47.29 million3/12/2025Q4 2024SKINBeauty Health-$0.10-$0.08+$0.02-$0.08$78.02 million$83.50 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIRMDIradimed$0.681.12%N/A43.87%1 YearsRXSTRxSightN/AN/AN/AN/AN/ASIBNSI-BONEN/AN/AN/AN/AN/ASKINBeauty HealthN/AN/AN/AN/AN/ALatest SKIN, SIBN, IRMD, and RXST DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/5/2025IRMDIradimedquarterly$0.171.3%5/20/20255/20/20255/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIRMDIradimedN/A9.217.82RXSTRxSightN/A12.6711.71SIBNSI-BONE0.228.257.22SKINBeauty Health9.236.565.57Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIRMDIradimed92.34%RXSTRxSight78.78%SIBNSI-BONE98.11%SKINBeauty Health93.26%Insider OwnershipCompanyInsider OwnershipIRMDIradimed36.80%RXSTRxSight9.36%SIBNSI-BONE4.00%SKINBeauty Health41.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIRMDIradimed11012.72 million7.97 millionOptionableRXSTRxSight22040.64 million36.53 millionOptionableSIBNSI-BONE35042.62 million40.30 millionOptionableSKINBeauty Health1,030125.99 million73.23 millionOptionableSKIN, SIBN, IRMD, and RXST HeadlinesRecent News About These CompaniesGlow from Head to Toe With My Beauty Editor-Approved Summer Skincare RoutineJune 5 at 2:07 AM | yahoo.comWhat Are Humectants in Hair and Skin Care Products?June 4 at 9:07 PM | msn.comThis Summer, My Beauty Editor-Approved Skincare Routine Gives Equal Love to My Body and FaceJune 4 at 4:05 PM | msn.com'I'm nearly 70 but look years younger - I won't leave the house without my go-to skin care product'June 4 at 11:05 AM | msn.comCan Cycle Syncing Your Skin Care Routine Improve Your Glow?June 4 at 11:05 AM | bustle.com5 powerful facial massage benefits transform skinJune 4 at 11:05 AM | rollingout.comBeautyHealth Surpasses 35,000 Hydrafacial Devices Worldwide Reflecting Growing Consumer Demand for Clinically Proven Skin Health TreatmentsJune 4 at 8:00 AM | globenewswire.com“Looks can kill”: Why this skin doctor says beauty is a health issueJune 3 at 1:59 PM | msn.comWhat Is a BB Cream? All About K-Beauty’s Favorite Foundation AlternativeJune 3 at 8:57 AM | vogue.comI Tried A New Injectable To Improve My Skin's Texture—And Now, My Complexion's Smoother Than EverJune 3 at 8:57 AM | msn.comKalahari melon oil: 5 benefits for healthy skinJune 3 at 3:56 AM | newsbytesapp.comRhode Skin By Hailey Bieber Review: These Beauty Essentials Have Transformed Our Beauty Team’s SkinJune 2 at 5:54 PM | msn.comThe best beauty products that A-list celebrities swear by - from moisturiser to supplementsJune 2 at 12:53 PM | rsvplive.ieShe Built a Beauty Brand That Centered Her Own Skin—and Millions FollowedJune 1, 2025 | msn.comSay goodbye to facial wrinkles with these nutrient-rich foods to get healthy skinJune 1, 2025 | indiatvnews.comFrom Green Tea To Laser Treatments, Lindsay Lohan Reveals The Secrets Behind Her Flawless SkinMay 31, 2025 | onlymyhealth.comThe Beauty Catch: 7 Ways Fish Oil Can Transform Your Skin, Hair, And NailsMay 31, 2025 | msn.comWant healthy and glowing skin in summer? Know the importance of AHA and BHA in skincare routineMay 30, 2025 | indiatvnews.comWhat's the Deal With Hypochlorous Acid, the Latest Skin Care Fad?May 30, 2025 | medpagetoday.comThis post-workout skin care routine will help prevent breakoutsMay 30, 2025 | msn.comMillennium Management LLC Raises Stake in The Beauty Health Company (NASDAQ:SKIN)May 30, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingNavitas Soars on NVIDIA Deal: Breaking Down Its Tech and OutlookBy Leo Miller | May 27, 2025View Navitas Soars on NVIDIA Deal: Breaking Down Its Tech and OutlookIs Energy Transfer Undervalued or a Value Trap?By Chris Markoch | May 8, 2025View Is Energy Transfer Undervalued or a Value Trap?SKIN, SIBN, IRMD, and RXST Company DescriptionsIradimed NASDAQ:IRMD$60.64 -0.14 (-0.23%) Closing price 03:59 PM EasternExtended Trading$60.64 0.00 (0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.RxSight NASDAQ:RXST$14.91 -0.35 (-2.31%) Closing price 03:59 PM EasternExtended Trading$14.92 +0.02 (+0.11%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.SI-BONE NASDAQ:SIBN$19.05 +0.56 (+3.01%) Closing price 03:59 PM EasternExtended Trading$19.07 +0.02 (+0.09%) As of 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.Beauty Health NASDAQ:SKIN$1.60 -0.08 (-4.49%) Closing price 03:59 PM EasternExtended Trading$1.60 +0.01 (+0.31%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio? Is Meta Plotting a Stablecoin Comeback Years After Libra's Flop? NVIDIA Regains Top Spot; FOMO Is Why It Will Continue to Rise Robinhood Stock Keeps Giving Investors Reasons To Buy Hims & Hers Stock: Buy the Dip or Wait It Out? Boeing: Analyst Upgrades & Order Boom Signal Clearer Skies CrowdStrike Stock Dips on Guidance Miss: It May Rebound Fast A New All-Time High Is Coming Soon for Credo Technology Group Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
